Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Find out which index fund best fits retirement accounts in 2024. Compare options and craft a solid retirement strategy today.
24,181 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
In this edition of the Morning Minute, Saylor is back to buying, signaling renewed confidence in Bitcoin. We break do...
A Digi International VP sold a stake amid a fast-changing IoT landscape. This article breaks down what such insider m...
An insider sold 50,000 shares of Hinge Health, prompting questions about the stock’s outlook. This guide breaks down ...
Palantir stock soared today as investors priced in a mix of solid results, new government and enterprise wins, and a ...
When a global star is spotted with a new rumored romance, the headlines aren't the only thing that shifts. This guide...
A leading robotic-assisted surgery platform maker is drawing long-term investor attention as it grows its recurring r...
Amazon briefly overtook SpaceX as the world's fifth-largest company by market cap. Here are three reasons that leader...
This article explores Baupost founder Seth Klarman's patient, risk-conscious investing style. Learn how his focus on ...
Salesforce CRM faces a sharp sell-off even as its AI strategy shows real monetization. Here’s why traders are watchin...
A strong earnings backdrop and improving fundamentals may be signaling a shift for Micron stock. This guide breaks do...
Investors are racing to price in the first real revenue opportunities from quantum tech as a new federal funding push...